Accelerating alzheimer’s therapy innovation: The power of blood-based biomarkers The escalating global challenge of Alzheimer's Disease (AD) demands new approaches to detection, diagnosis, and treatment.

https://www.questdiagnostics.com/business-solutions/life-sciences/pharma-solutions/neurology/whitepaper-ad?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz--z504Hah4-K4HZO2iHDO8sJetV30iTvhQjPA-YrTVw0AkR1qxG_oznfwl74GUDQYHW6CjQOYK0SQ0LLGxUev_YIhAq_g&_hsmi=325182134&utm_content=325182134&utm_source=hs_email